You are here: Home » News-CM » Companies » News
Business Standard

Zydus receives final approval from the USFDA for Zolmitriptan Tablets USP

Capital Market 

has received the final approval from the USFDA to market Tablets, 2.5 mg and 5 mg.

It is used to treat It helps to relieve headache, and other symptoms (including nausea, and sensitivity to light/sound). It will be manufactured at the group's at Moraiya, Ahmedabad.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, July 12 2018. 10:32 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU